<p><b>(A)</b> Three different human RCC derived cell lines were seeded on 96-well plates at a concentration of 1x10<sup>4</sup> cells/well in triplicate and were treated with HCQ from 0 to 125 μM. After 48 hours, cell growth was measured using an MTT assay. Error bars show standard deviation, and the letter at top indicates statistically significant differences between columns with different letters (P<0.05, ANOVA with Tukey post-hoc test). <b>(B)</b> Indicated cell lines were incubated with either nothing, RAD001 (10 μM), HCQ (75 μM) or combination of RAD001 and HCQ for two days. Growth was measured as in (A). <b>(C)</b> RCC cells were cultured in the absence (C) or presence of either 10 μM RAD001 (R) or 75 μM HCQ (H) for two days, and Wes...
(A) Cell apoptosis was detected by flow cytometry. Compared with the control group, *P 0.05, compar...
<p>(A) Freshly isolated mouse splenocytes were treated with indicated concentrations of PCP or TCHQ ...
<p>(A) Cells were treated with CQ (50 μM) or 3-MA (5 mM) and/or cisplatin (10 or 20 μg/ml) for 24 h ...
<p>Cells were pre-treated overnight with 2000 ng/mL HCQ. The following day cells were exposed to sim...
<p>(A) Viability graph of RCC4 cells treated with 10 µM or 20 µM CQ, 20 µM CCI-779 or combination of...
(A) Cell viability of HT29 cell lines was measured, using the MTT assay, after treatment of cells fo...
<p>(<b>A</b>) Upper panel: percentage of annexin V/PI positive cells 5 d after treatment with CQ alo...
<p>(A, B) Two cancer cell lines were cultured with CQ (200 nM for MiaPaCa-2 and 700 nM for Panc-1) a...
The percentage of viable and necrotic cells was measured by high-content analysis at different time ...
<p>(A) Hep G2, SMMC7721 and LO2 cells treated with ARG (0, 1.56, 12.5, 100 μM) for 24 h were double-...
<p>(A) Two cancer cell lines were cultured with the indicated doses of TRAIL and CQ for 48 h. After ...
<p>(A) LC3 immunoblotting in human RCC cell lines. Human RCC cells have high basal autophagy as indi...
<p>(A) DHM-induced apoptosis in HepG2 cells with different concentrations (a: control, b: 10 μM, c: ...
<p>(A) Phase contrast images showing morphology of HOS untreated (i), CDDP (IC<sub>50</sub>) treated...
<p>(A) The number of hICD-expressing cells was significantly lower than that of control cells when c...
(A) Cell apoptosis was detected by flow cytometry. Compared with the control group, *P 0.05, compar...
<p>(A) Freshly isolated mouse splenocytes were treated with indicated concentrations of PCP or TCHQ ...
<p>(A) Cells were treated with CQ (50 μM) or 3-MA (5 mM) and/or cisplatin (10 or 20 μg/ml) for 24 h ...
<p>Cells were pre-treated overnight with 2000 ng/mL HCQ. The following day cells were exposed to sim...
<p>(A) Viability graph of RCC4 cells treated with 10 µM or 20 µM CQ, 20 µM CCI-779 or combination of...
(A) Cell viability of HT29 cell lines was measured, using the MTT assay, after treatment of cells fo...
<p>(<b>A</b>) Upper panel: percentage of annexin V/PI positive cells 5 d after treatment with CQ alo...
<p>(A, B) Two cancer cell lines were cultured with CQ (200 nM for MiaPaCa-2 and 700 nM for Panc-1) a...
The percentage of viable and necrotic cells was measured by high-content analysis at different time ...
<p>(A) Hep G2, SMMC7721 and LO2 cells treated with ARG (0, 1.56, 12.5, 100 μM) for 24 h were double-...
<p>(A) Two cancer cell lines were cultured with the indicated doses of TRAIL and CQ for 48 h. After ...
<p>(A) LC3 immunoblotting in human RCC cell lines. Human RCC cells have high basal autophagy as indi...
<p>(A) DHM-induced apoptosis in HepG2 cells with different concentrations (a: control, b: 10 μM, c: ...
<p>(A) Phase contrast images showing morphology of HOS untreated (i), CDDP (IC<sub>50</sub>) treated...
<p>(A) The number of hICD-expressing cells was significantly lower than that of control cells when c...
(A) Cell apoptosis was detected by flow cytometry. Compared with the control group, *P 0.05, compar...
<p>(A) Freshly isolated mouse splenocytes were treated with indicated concentrations of PCP or TCHQ ...
<p>(A) Cells were treated with CQ (50 μM) or 3-MA (5 mM) and/or cisplatin (10 or 20 μg/ml) for 24 h ...